Palobiofarma Partners with Flex Databases for Advanced Pharmacovigilance Management

Palobiofarma Partners with Flex Databases for Advanced Pharmacovigilance Management
February 6, 2025

Palobiofarma, a leading clinical-stage biotech company, has chosen Flex Databases to upgrade its pharmacovigilance management system, ensuring scalability and efficiency as it expands its clinical trials and pipeline of drug candidates. The company’s commitment to pioneering medicine, particularly through its work on PBF-999 for Prader-Willi Syndrome, has propelled its growth and highlighted the need for a more robust and flexible system to manage complex clinical data.

Why Palobiofarma Chose Flex Databases

As Palobiofarma's clinical pipeline has expanded, so has the complexity of its clinical trials. This has led to the need for a more advanced and scalable PV solution. The flexibility, simplicity, and competitive pricing of Flex Databases’ pharmacovigilance module stood out during the evaluation process. The team also valued the company's exceptional customer support, which made their decision easier and more informed.

Key Features that Mattered

Palobiofarma required a PV solution that would streamline processes while offering comprehensive data entry, robust reporting capabilities, and user-friendly design. Flex Databases’ PV module met all of these requirements, with the added benefit of integration options with other key systems, such as Trial Master File (TMF), document management, and Clinical Trial Management System (CTMS), allowing for future scalability and seamless growth.

A Seamless Experience with Flex Databases

Throughout the selection process, Palobiofarma experienced unparalleled support from Flex Databases. Despite a prolonged decision-making period, the Flex team’s patience and constant guidance were instrumental in reassuring Palobiofarma of their choice. A dedicated project manager was assigned to the project, ensuring smooth implementation and timely migration of legacy data, and providing valuable support through every phase of the transition.

Looking Ahead: A Year After Implementation

A year after system implementation, Palobiofarma plans to achieve full migration of its legacy data and maximize the potential of Flex Databases’ PV module. The company will also explore further integration with other Flex Databases modules, continuing to optimize clinical trial processes for greater operational efficiency and compliance.

Flex Databases continues to provide Palobiofarma with the right tools and support to help manage growing demands in pharmacovigilance, as the biotech company focuses on delivering innovative solutions for patients worldwide.